City of Hope (Duarte, Calif.). City of Hope dates back to 1913, when it was founded as a tuberculosis hospital. Over the last century, it grew into what it is today, a Comprehensive Cancer Center as designated by the National Cancer Institute and a founding member of the National Comprehensive Cancer Network. Researchers at City of Hope have pioneered many new cancer drugs, including Herceptin, Rituxan and Avastin, and the hospital holds more than 300 patents. U.S. News & World Report ranked City of Hope as No. 20 in the nation for cancer care for 2016-17.
 |
 
|
.
|
|
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.